CHDI Foundation Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CHDI Foundation Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9273
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CHDI Foundation Inc (CHDI) is a non-profit biomedical research organization that discovers and develops drugs for Huntington’s disease. The organization’s activities include identification and validation of therapeutic targets, drug discovery and development, and clinical studies and trials. It also conducts preclinical research programs such as discovery biology, translational biology, and medicinal chemistry. CHDI manages a portfolio of research projects to connect academic research, drug discovery and clinical development. The organization funds and partners with academic researchers in universities across the world. It operates its offices in Los Angeles, New York and Princeton, the US. CHDI is headquartered in Los Angeles, California, the US.

CHDI Foundation Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CHDI Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CHDI Foundation Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CHDI Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CHDI Foundation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CHDI Foundation Inc, Medical Devices Deals, 2012 to YTD 2018 9
CHDI Foundation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CHDI Foundation Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
PTC Therapeutics Enters into Agreement with CHDI Foundation 11
Voyager Therapeutics Enters into Research Agreement with CHDI Foundation 12
Singulex Enters into Development Agreement with CHDI Foundation 13
GNS Healthcare Enters into Agreement with CHDI Foundation 14
Charles River Lab Extends Co-Development Agreement with CHDI Foundation 15
Proteome Sciences Enters Into Co-Development Agreement With CHDI Foundation 16
GNS Healthcare Enters Into Co-Development Agreement With CHDI Foundation 17
CHDI Foundation Inc – Key Competitors 18
CHDI Foundation Inc – Key Employees 19
CHDI Foundation Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Government and Public Interest 21
Mar 28, 2018: C-Path and CHDI launch consortium to accelerate development of Huntingtons disease therapies 21
Product News 22
Sep 13, 2018: Blood and brain fluid change first in Huntington’s disease 22
Jul 26, 2017: LTHT Huntington’s disease trial success 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
CHDI Foundation Inc, Pharmaceuticals & Healthcare, Key Facts 2
CHDI Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CHDI Foundation Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CHDI Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CHDI Foundation Inc, Deals By Therapy Area, 2012 to YTD 2018 8
CHDI Foundation Inc, Medical Devices Deals, 2012 to YTD 2018 9
CHDI Foundation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
PTC Therapeutics Enters into Agreement with CHDI Foundation 11
Voyager Therapeutics Enters into Research Agreement with CHDI Foundation 12
Singulex Enters into Development Agreement with CHDI Foundation 13
GNS Healthcare Enters into Agreement with CHDI Foundation 14
Charles River Lab Extends Co-Development Agreement with CHDI Foundation 15
Proteome Sciences Enters Into Co-Development Agreement With CHDI Foundation 16
GNS Healthcare Enters Into Co-Development Agreement With CHDI Foundation 17
CHDI Foundation Inc, Key Competitors 18
CHDI Foundation Inc, Key Employees 19
CHDI Foundation Inc, Other Locations 20

List of Figures
CHDI Foundation Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CHDI Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CHDI Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CHDI Foundation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CHDI Foundation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CHDI Foundation Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CHDI Foundation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CHDI Foundation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CHDI Foundation Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[CHDI Foundation Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Arise AB (ARISE):企業の財務・戦略的SWOT分析
    Arise AB (ARISE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Rubius Therapeutics Inc (RUBY):製薬・医療:M&Aディール及び事業提携情報
    Summary Rubius Therapeutics Inc (Rubius Therapeutics) is a biotechnology company that focuses on the development of medicines for the treatment of rare diseases, cancer and autoimmune diseases. The company through its rubius erythrocyte design (RED) platform engineer and culture Red Cell Therapeutic …
  • Pacific Scientific Energetic Materials Company:企業の戦略・SWOT・財務分析
    Pacific Scientific Energetic Materials Company - Strategy, SWOT and Corporate Finance Report Summary Pacific Scientific Energetic Materials Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Empresa Electricidad del Peru SA (ELECPBC1):企業の財務・戦略的SWOT分析
    Empresa Electricidad del Peru SA (ELECPBC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • PT. Indonesia Power:発電所・企業SWOT分析
    PT. Indonesia Power - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • IP Group Plc (IPO):企業の財務・戦略的SWOT分析
    Summary IP Group Plc (IP Group) is a provider of venture capital, business building and support, networks and recruitment services. The company invests in companies, which comprise early stage to mature businesses from various sectors such as energy and renewables, medical equipment and supplies, ph …
  • Avior Integrated Products Inc.:企業の戦略・SWOT・財務情報
    Avior Integrated Products Inc. - Strategy, SWOT and Corporate Finance Report Summary Avior Integrated Products Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Kaiser Foundation Health Plan Inc:企業の戦略的SWOT分析
    Kaiser Foundation Health Plan Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • First Pacific Company Limited:企業の戦略・SWOT・財務情報
    First Pacific Company Limited - Strategy, SWOT and Corporate Finance Report Summary First Pacific Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • National Institutes of Health-製薬・医療分野:企業M&A・提携分析
    Summary National Institutes of Health (NIH) a subsidiary of U.S. Department of Health and Human Services is a biomedical research institute that discovers and develops research strategies for the improvement of health. The institute's medical research initiatives includes environmental influence on …
  • Western Iowa Energy LLC:企業の戦略的SWOT分析
    Western Iowa Energy LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Helena Laboratories Corp:企業の製品パイプライン分析2018
    Summary Helena Laboratories Corp (Helena) is a medical device company that provides clinical laboratory instruments. The company offers electrophoresis analyzers, densitometers, electrophoresis supplies, hemostasis instruments, spife replacement pump, immunology and protein diagnostic products. It o …
  • Santa Fe Group A/S:企業の戦略・SWOT・財務情報
    Santa Fe Group A/S - Strategy, SWOT and Corporate Finance Report Summary Santa Fe Group A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Caplin Point Laboratories Ltd (CAPLIPOINT):企業の財務・戦略的SWOT分析
    Summary Caplin Point Laboratories Ltd (Caplin Point) is a pharmaceutical company that manufactures creams, ointments, and other external application products. The company’s products in regulated market include opthalmic products, liquid injections and lyophilised injections. It also offers softgel c …
  • Gulfsands Petroleum plc (GPX):企業の財務・戦略的SWOT分析
    Summary Gulfsands Petroleum plc (Gulfsands) is an oil and gas company that offers exploration, development, and production services. The company carries out acquisition, exploration, develops, and produces oil and natural gas. It holds interests in oil exploration and development projects in the Syr …
  • Cooperativa Muratori & Cementisti C.M.C di Ravenna:企業の戦略・SWOT・財務情報
    Cooperativa Muratori & Cementisti C.M.C di Ravenna - Strategy, SWOT and Corporate Finance Report Summary Cooperativa Muratori & Cementisti C.M.C di Ravenna - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Pacific Biosciences of California Inc (PACB):企業の財務・戦略的SWOT分析
    Pacific Biosciences of California Inc (PACB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Future Plc (FUTR):企業の財務・戦略的SWOT分析
    Summary Future Plc (Future) is a media company that offers media and digital business solutions various customers. The company offers its services in various areas such as technology, creative, photography and design, games, advertising and film and music. It provides licensing and syndication, expo …
  • SI-Bone Inc (SIBN):医療機器:M&Aディール及び事業提携情報
    Summary SI-Bone Inc (SI-BONE) is a medical device company that develops, manufactures and distributes diagnosing and treating patients with SI joint disorders products and tools. The company offers medical devices for patients with low back issues, degenerative sacroiliitis, and SI joint disruptions …
  • NextEra Energy Resources LLC:企業の戦略的SWOT分析
    NextEra Energy Resources LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆